for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

REFILE-JNJ COVID-19 vaccine delayed by U.S. manufacturing issues -NYT

(Adds source in the headline)

March 31 (Reuters) - About 15 million doses of Johnson & Johnson’s COVID-19 vaccine have been ruined due to a mixup at a Baltimore plant, forcing regulators to delay authorization of the plant’s production lines, New York Times reported on Wednesday.

The plant is run by Emergent BioSolutions, a manufacturing partner to both Johnson & Johnson and AstraZeneca Plc, according to the report.

Reporting by Dania Nadeem in Bengaluru; Editing by Anil D’Silva

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up